Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing

Megan A. Allyse; David H. Robinson; Matthew J. Ferber; Richard R. Sharp

doi:10.1016/j.mayocp.2017.11.001

Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing

Megan A. Allyse, David H. Robinson, Matthew J. Ferber, Richard R. Sharp

Research output: Contribution to journal › Review article › peer-review

61 Scopus citations

Abstract

Direct-to-consumer (DTC) genetic testing emerged in the early 2000s as a means of allowing consumers to access information on their genetics without the involvement of a physician. Although early models of DTC were popular with consumers, they were controversial in medical and regulatory circles. In this article, we trace the history of DTC genetic testing, discuss its regulatory implications, and describe the emergence of a new hybrid model we call DTC 2.0.

Original language	English (US)
Pages (from-to)	113-120
Number of pages	8
Journal	Mayo Clinic proceedings
Volume	93
Issue number	1
DOIs	https://doi.org/10.1016/j.mayocp.2017.11.001
State	Published - Jan 2018

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.mayocp.2017.11.001

Cite this

@article{4eb53ed134b7405ba4c656226c015360,

title = "Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing",

abstract = "Direct-to-consumer (DTC) genetic testing emerged in the early 2000s as a means of allowing consumers to access information on their genetics without the involvement of a physician. Although early models of DTC were popular with consumers, they were controversial in medical and regulatory circles. In this article, we trace the history of DTC genetic testing, discuss its regulatory implications, and describe the emergence of a new hybrid model we call DTC 2.0.",

author = "Allyse, {Megan A.} and Robinson, {David H.} and Ferber, {Matthew J.} and Sharp, {Richard R.}",

note = "Publisher Copyright: {\textcopyright} 2017 Mayo Foundation for Medical Education and Research",

year = "2018",

month = jan,

doi = "10.1016/j.mayocp.2017.11.001",

language = "English (US)",

volume = "93",

pages = "113--120",

journal = "Mayo Clinic proceedings",

issn = "0025-6196",

publisher = "Elsevier Science",

number = "1",

}

TY - JOUR

T1 - Direct-to-Consumer Testing 2.0

T2 - Emerging Models of Direct-to-Consumer Genetic Testing

AU - Allyse, Megan A.

AU - Robinson, David H.

AU - Ferber, Matthew J.

AU - Sharp, Richard R.

PY - 2018/1

Y1 - 2018/1

N2 - Direct-to-consumer (DTC) genetic testing emerged in the early 2000s as a means of allowing consumers to access information on their genetics without the involvement of a physician. Although early models of DTC were popular with consumers, they were controversial in medical and regulatory circles. In this article, we trace the history of DTC genetic testing, discuss its regulatory implications, and describe the emergence of a new hybrid model we call DTC 2.0.

AB - Direct-to-consumer (DTC) genetic testing emerged in the early 2000s as a means of allowing consumers to access information on their genetics without the involvement of a physician. Although early models of DTC were popular with consumers, they were controversial in medical and regulatory circles. In this article, we trace the history of DTC genetic testing, discuss its regulatory implications, and describe the emergence of a new hybrid model we call DTC 2.0.

UR - http://www.scopus.com/inward/record.url?scp=85038910279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038910279&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2017.11.001

DO - 10.1016/j.mayocp.2017.11.001

M3 - Review article

C2 - 29304915

AN - SCOPUS:85038910279

SN - 0025-6196

VL - 93

SP - 113

EP - 120

JO - Mayo Clinic proceedings

JF - Mayo Clinic proceedings

IS - 1

ER -

Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this